Merck Reports Third-Quarter EPS of $2.04

Merck reported third-quarter 2026 sales of $18.1 billion, up 5%, and diluted GAAP EPS of $2.04. Non-GAAP EPS was $2.49, including a one-time charge related to a global license agreement with SciBrunch. The company raised the midpoint of its full-year sales and non-GAAP EPS outlook.Financial Highlig…